AAAAAA

   
Results: 1-13 |
Results: 13
PHASE-I TRIAL OF SUBCUTANEOUS INTERLEUKIN-3 IN PATIENTS WITH REFRACTORY MALIGNANCY - HEMATOLOGICAL, IMMUNOLOGICAL, AND PHARMACODYNAMIC FINDINGS
Authors: BUKOWSKI RM OLENCKI T GUNN H MCLAIN D BUDD GT SANDSTROM K TUASON L REDOVAN C RAYMAN P TUBBS R RESTA D ELSON P FINKE J
Citation: Rm. Bukowski et al., PHASE-I TRIAL OF SUBCUTANEOUS INTERLEUKIN-3 IN PATIENTS WITH REFRACTORY MALIGNANCY - HEMATOLOGICAL, IMMUNOLOGICAL, AND PHARMACODYNAMIC FINDINGS, Clinical cancer research, 2(2), 1996, pp. 347-357
RECOMBINANT HUMAN INTERLEUKIN-3 (RHIL-3) ENHANCES THE MOBILIZATION OFPERIPHERAL-BLOOD PROGENITOR CELLS BY RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR (RHG-CSF) IN NORMAL VOLUNTEERS
Authors: HUHN RD YURKOW EJ TUSHINSKI R CLARKE L STURGILL MG HOFFMAN R SHEAY W CODY R PHILIPP C RESTA D GEORGE M
Citation: Rd. Huhn et al., RECOMBINANT HUMAN INTERLEUKIN-3 (RHIL-3) ENHANCES THE MOBILIZATION OFPERIPHERAL-BLOOD PROGENITOR CELLS BY RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR (RHG-CSF) IN NORMAL VOLUNTEERS, Experimental hematology, 24(7), 1996, pp. 839-847
COMPARISON OF 4 CYTOKINE REGIMENS FOR MOBILIZATION OF PERIPHERAL-BLOOD STEM-CELLS - IL-3 ALONE AND COMBINED WITH GM-CSF OR G-CSF
Authors: ROSENFELD CS BOLWELL B LEFEVER A TAYLOR R LIST A FAY J COLLINS R ANDREWS F PALLANSCH P SCHUSTER MW RESTA D LEVITT D NEMUNAITIS J
Citation: Cs. Rosenfeld et al., COMPARISON OF 4 CYTOKINE REGIMENS FOR MOBILIZATION OF PERIPHERAL-BLOOD STEM-CELLS - IL-3 ALONE AND COMBINED WITH GM-CSF OR G-CSF, Bone marrow transplantation, 17(2), 1996, pp. 179-183
PHASE-I TRIAL OF RECOMBINANT INTERLEUKIN-3 BEFORE AND AFTER CARBOPLATIN ETOPOSIDE CHEMOTHERAPY IN PATIENTS WITH SOLID TUMORS - A SOUTHWEST-ONCOLOGY-GROUP STUDY
Authors: RINEHART J MARGOLIN KA TRIOZZI P HERSH E CAMPION M RESTA D LEVITT D
Citation: J. Rinehart et al., PHASE-I TRIAL OF RECOMBINANT INTERLEUKIN-3 BEFORE AND AFTER CARBOPLATIN ETOPOSIDE CHEMOTHERAPY IN PATIENTS WITH SOLID TUMORS - A SOUTHWEST-ONCOLOGY-GROUP STUDY, Clinical cancer research, 1(10), 1995, pp. 1139-1144
PHARMACODYNAMICS OF DAILY SUBCUTANEOUS RECOMBINANT HUMAN INTERLEUKIN-3 IN NORMAL VOLUNTEERS
Authors: HUHN RD YURKOW EJ KUHN JG CLARKE L GUNN H RESTA D SHAH R MYERS LA SEIBOLD JR
Citation: Rd. Huhn et al., PHARMACODYNAMICS OF DAILY SUBCUTANEOUS RECOMBINANT HUMAN INTERLEUKIN-3 IN NORMAL VOLUNTEERS, Clinical pharmacology and therapeutics, 57(1), 1995, pp. 32-41
A PHASE I II STUDY OF INTERLEUKIN-3 IN PATIENTS WITH APLASTIC-ANEMIA AND MYELODYSPLASIA/
Authors: NIMER SD PAQUETTE RL IRELAND P RESTA D YOUNG D GOLDE DW
Citation: Sd. Nimer et al., A PHASE I II STUDY OF INTERLEUKIN-3 IN PATIENTS WITH APLASTIC-ANEMIA AND MYELODYSPLASIA/, Experimental hematology, 22(9), 1994, pp. 875-880
EFFECT OF RECOMBINANT HUMAN INTERLEUKIN-3 ON HEMATOLOGICAL RECOVERY FROM CHEMOTHERAPY-INDUCED MYELOSUPPRESSION
Authors: TEPLER I ELIAS A KALISH L SHULMAN L STRAUSS G SKARIN A LYNCH T LEVITT D RESTA D DEMETRI G GAYNES L SCHNIPPER L
Citation: I. Tepler et al., EFFECT OF RECOMBINANT HUMAN INTERLEUKIN-3 ON HEMATOLOGICAL RECOVERY FROM CHEMOTHERAPY-INDUCED MYELOSUPPRESSION, British Journal of Haematology, 87(4), 1994, pp. 678-686
A PHASE-II TRIAL OF G-CSF WITH OR WITHOUT SDZ ILE-964 (IL-3) FOR THE MOBILIZATION OF PERIPHERAL-BLOOD PROGENITOR CELLS (PBPC) FOR AUTOLOGOUS PROGENITOR-CELL TRANSPLANTATION
Authors: BOLWELL B ROSENFELD C LEFEVER A LIST A ANDREWS F SCHUSTER M LEVITT D RESTA D GEORGE M NEMUNAITIS J COLLINS R
Citation: B. Bolwell et al., A PHASE-II TRIAL OF G-CSF WITH OR WITHOUT SDZ ILE-964 (IL-3) FOR THE MOBILIZATION OF PERIPHERAL-BLOOD PROGENITOR CELLS (PBPC) FOR AUTOLOGOUS PROGENITOR-CELL TRANSPLANTATION, Blood, 84(10), 1994, pp. 10000106-10000106
PRIMING WITH RECOMBINANT HUMAN INTERLEUKIN-3 (RHIL-3) ENHANCES THE MOBILIZATION OF BLOOD PROGENITOR CELLS (PBPC) BY RH-GRANULOCYTE COLONY-STIMULATING FACTOR (RHG-CSF) IN NORMAL VOLUNTEERS
Authors: HUHN RD YURKOW EJ TUSHINSKI R HOFFMAN R CLARKE L SHEAY W PHILLIPP C STURGILL M GEORGE M RESTA D SEIBOLD JR
Citation: Rd. Huhn et al., PRIMING WITH RECOMBINANT HUMAN INTERLEUKIN-3 (RHIL-3) ENHANCES THE MOBILIZATION OF BLOOD PROGENITOR CELLS (PBPC) BY RH-GRANULOCYTE COLONY-STIMULATING FACTOR (RHG-CSF) IN NORMAL VOLUNTEERS, Blood, 84(10), 1994, pp. 10000541-10000541
PHASE-I TRIAL WITH RECOMBINANT HUMAN INTERLEUKIN-3 IN PATIENTS WITH LYMPHOMA UNDERGOING AUTOLOGOUS BONE-MARROW TRANSPLANTATION
Authors: NEMUNAITIS J APPELBAUM FR SINGER JW LILLEBY K WOLFF S GREER JP BIERMAN P RESTA D CAMPION M LEVITT D ZEIGLER Z ROSENFELD C SHADDUCK RK BUCKNER CD
Citation: J. Nemunaitis et al., PHASE-I TRIAL WITH RECOMBINANT HUMAN INTERLEUKIN-3 IN PATIENTS WITH LYMPHOMA UNDERGOING AUTOLOGOUS BONE-MARROW TRANSPLANTATION, Blood, 82(11), 1993, pp. 3273-3278
PHASE-II RANDOMIZED TRIAL COMPARING SDZ-ILE-964 (RHIL-3) TO SEQUENTIAL AND COMBINATION ADMINISTRATION OF RHIL-3 AND LEUKINE(R) OR NEUPOGEN(R) IN THE MOBILIZATION OF PERIPHERAL-BLOOD PROGENITOR CELLS FOR AUTOLOGOUS TRANSPLANT (PBSCT) IN PATIENTS WITH LYMPHOID MALIGNANCY OR BREAST-CANCER
Authors: NEMUNAITIS J ROSENFELD C BOLWELL B LEFEVER A TAYLOR R FAY J COLLINS R LIST A SCHUSTER M RESTA D PALLANSCH P LEVITT D
Citation: J. Nemunaitis et al., PHASE-II RANDOMIZED TRIAL COMPARING SDZ-ILE-964 (RHIL-3) TO SEQUENTIAL AND COMBINATION ADMINISTRATION OF RHIL-3 AND LEUKINE(R) OR NEUPOGEN(R) IN THE MOBILIZATION OF PERIPHERAL-BLOOD PROGENITOR CELLS FOR AUTOLOGOUS TRANSPLANT (PBSCT) IN PATIENTS WITH LYMPHOID MALIGNANCY OR BREAST-CANCER, Blood, 82(10), 1993, pp. 10000365-10000365
SIMULTANEOUS INTERLEUKIN-3 (IL-3) AND GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) ADMINISTRATION AFTER HIGH-DOSE CHEMOTHERAPY(HDCT) IN PATIENTS WITH ADVANCED CANCER
Authors: BOWERS C ADKINS D DUNPHY F PETRUSKA P VELASQUEZ W MCINTYRE W NIEMEYER R RESTA D SPITZER G
Citation: C. Bowers et al., SIMULTANEOUS INTERLEUKIN-3 (IL-3) AND GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) ADMINISTRATION AFTER HIGH-DOSE CHEMOTHERAPY(HDCT) IN PATIENTS WITH ADVANCED CANCER, Blood, 82(10), 1993, pp. 10000495-10000495
CLINICAL AND HEMATOPOIETIC EFFECTS OF RECOMBINANT HUMAN INTERLEUKIN-3ADMINISTERED BY DAILY SUBCUTANEOUS INJECTION TO HEALTHY NORMAL VOLUNTEERS
Authors: HUHN RD YURKOW EJ CLARKE L RESTA D SORANNO T SEIBOLD JR MYERS LA
Citation: Rd. Huhn et al., CLINICAL AND HEMATOPOIETIC EFFECTS OF RECOMBINANT HUMAN INTERLEUKIN-3ADMINISTERED BY DAILY SUBCUTANEOUS INJECTION TO HEALTHY NORMAL VOLUNTEERS, Blood, 82(10), 1993, pp. 10000500-10000500
Risultati: 1-13 |